These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 30229510

  • 21. The beliefs, and reported and intended behaviors of unaffected men in response to their family history of prostate cancer.
    Cowan R, Meiser B, Giles GG, Lindeman GJ, Gaff CL.
    Genet Med; 2008 Jun; 10(6):430-8. PubMed ID: 18496220
    [Abstract] [Full Text] [Related]

  • 22. Estimating preferences for treatments in patients with localized prostate cancer.
    Ávila M, Becerra V, Guedea F, Suárez JF, Fernandez P, Macías V, Mariño A, Hervás A, Herruzo I, Ortiz MJ, Ponce de León J, Sancho G, Cunillera O, Pardo Y, Cots F, Ferrer M, Multicentric Spanish Group of Clinically Localized Prostate Cancer.
    Int J Radiat Oncol Biol Phys; 2015 Feb 01; 91(2):277-87. PubMed ID: 25491504
    [Abstract] [Full Text] [Related]

  • 23. [Acceptance of the disease and tendency to pay higher health insurance fee by patients with lung cancer].
    Nowicki A, Graczyk P, Farbicka P.
    Wiad Lek; 2017 Feb 01; 70(3 pt 2):547-552. PubMed ID: 28713079
    [Abstract] [Full Text] [Related]

  • 24. Association of serum lipid levels and prostate cancer severity among Hispanic Puerto Rican men.
    Salgado-Montilla J, Soto Salgado M, Surillo Trautmann B, Sánchez-Ortiz R, Irizarry-Ramírez M.
    Lipids Health Dis; 2015 Sep 17; 14():111. PubMed ID: 26377420
    [Abstract] [Full Text] [Related]

  • 25. Diversity of cancer-related identities in long-term prostate cancer survivors after radical prostatectomy.
    Jahnen M, Mynzak E, Meissner VH, Schiele S, Schulwitz H, Ankerst DP, Gschwend JE, Herkommer K, Dinkel A.
    BMC Cancer; 2021 Sep 20; 21(1):1041. PubMed ID: 34544381
    [Abstract] [Full Text] [Related]

  • 26. The effect of comorbidity and socioeconomic status on sexual and urinary function and on general health-related quality of life in men treated with radical prostatectomy for localized prostate cancer.
    Karakiewicz PI, Bhojani N, Neugut A, Shariat SF, Jeldres C, Graefen M, Perrotte P, Peloquin F, Kattan MW.
    J Sex Med; 2008 Apr 20; 5(4):919-927. PubMed ID: 18371045
    [Abstract] [Full Text] [Related]

  • 27. Understanding of multigene test results among males undergoing germline testing for inherited prostate cancer: Implications for genetic counseling.
    Giri VN, Obeid E, Hegarty SE, Gross L, Bealin L, Hyatt C, Fang CY, Leader A.
    Prostate; 2018 Sep 20; 78(12):879-888. PubMed ID: 29655297
    [Abstract] [Full Text] [Related]

  • 28. The Willingness-to-Pay for General Practitioners in Contractual Service and Influencing Factors among Empty Nesters in Chongqing, China.
    Chen F, Xu XL, Yang Z, Tan HW, Zhang L.
    Int J Environ Res Public Health; 2015 Aug 10; 12(8):9330-41. PubMed ID: 26266416
    [Abstract] [Full Text] [Related]

  • 29. Prevalence of the HOXB13 G84E mutation in Danish men undergoing radical prostatectomy and its correlations with prostate cancer risk and aggressiveness.
    Storebjerg TM, Høyer S, Kirkegaard P, Bro F, LuCamp Study Group, Ørntoft TF, Borre M, Sørensen KD.
    BJU Int; 2016 Oct 10; 118(4):646-53. PubMed ID: 26779768
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Willingness to pay for colorectal cancer screening in Guangzhou.
    Zhou Q, Li Y, Liu HZ, Liang YR, Lin GZ.
    World J Gastroenterol; 2018 Nov 07; 24(41):4708-4715. PubMed ID: 30416318
    [Abstract] [Full Text] [Related]

  • 32. Comparing High-Intensity Focal Ultrasound Hemiablation to Robotic Radical Prostatectomy in the Management of Unilateral Prostate Cancer: A Matched-Pair Analysis.
    Albisinni S, Aoun F, Bellucci S, Biaou I, Limani K, Hawaux E, Peltier A, van Velthoven R.
    J Endourol; 2017 Jan 07; 31(1):14-19. PubMed ID: 27799004
    [Abstract] [Full Text] [Related]

  • 33. Assessment of demand for prenatal diagnostic testing using willingness to pay.
    Caughey AB, Washington AE, Gildengorin V, Kuppermann M.
    Obstet Gynecol; 2004 Mar 07; 103(3):539-45. PubMed ID: 14990419
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Family history of prostate cancer and obesity in relation to high-grade disease and extraprostatic extension in young men with prostate cancer.
    Rohrmann S, Roberts WW, Walsh PC, Platz EA.
    Prostate; 2003 May 01; 55(2):140-6. PubMed ID: 12661039
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Men's values-based factors on prostate cancer risk genetic testing: a telephone survey.
    Doukas DJ, Li Y.
    BMC Med Genet; 2004 Dec 10; 5():28. PubMed ID: 15588314
    [Abstract] [Full Text] [Related]

  • 39. Prognostic accuracy of Prostate Health Index and urinary Prostate Cancer Antigen 3 in predicting pathologic features after radical prostatectomy.
    Cantiello F, Russo GI, Ferro M, Cicione A, Cimino S, Favilla V, Perdonà S, Bottero D, Terracciano D, De Cobelli O, Morgia G, Damiano R.
    Urol Oncol; 2015 Apr 10; 33(4):163.e15-23. PubMed ID: 25575715
    [Abstract] [Full Text] [Related]

  • 40. Health care spending in prostate cancer: An assessment of characteristics and health care utilization of high resource-patients.
    Sun M, Marchese M, Friedlander DF, Nguyen DD, Cole AP, Fletcher SA, Mahal BA, Nguyen PL, Choueiri TK, Kibel AS, Trinh QD.
    Urol Oncol; 2021 Feb 10; 39(2):130.e17-130.e24. PubMed ID: 33309298
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.